National Institute on Alcohol Abuse and Alcoholism (NIAAA)
George Kunos MD. , PhD. Chief National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5625 Fishers Lane, Room 2S-24:MSC 9413 Bethesda MD 20892-9413 telephone: +1 301.443.2069 fax: +1 301.480.0257 e-mail: gkunos@mail.nih.gov Mission Statement The Biology and Functions of the Endocannabinoid System Endocannabinoids are lipid-like mediators discovered in the 1 990s that bind to cannabinoid receptors to trigger...
Neurokinin-1 receptors (NK1R) are highly expressed in brain areas involved in stress responses and drug reward. In recent years, mounting research evidence has suggested that they may help regulate important aspects of alcohol use. In a new study, researchers at the NIAAA report that a compound that blocks NK1R suppresses alcohol drinking in mice. NIAAA Clinical Director Markus Heilig, M.D...
The NIH Institute on Alcohol and Alcohol Abuse (NIAAA) has issued a national challenge to design a wearable or discreet device to measure blood alcohol levels. Tonight’s discussion examines the history and current research on alcohol consumption and the promise of new technology. First used by the criminal justice system to enforce drunk driving laws, alcohol monitoring technology now has...
Data Access Policy, Application and Agreement NIAAA Protocol NCIG 001: A Multisite Double-Blind, Placebo-Controlled Trial of Quetiapine Fumarate XR in Very Heavy-Drinking Alcohol-Dependent Patients Description This double-blind, randomized placebo-controlled trial evaluated the efficacy and safety of quetiapine, for the treatment of alcohol use disorder (AUD). Study Details Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) ...
National Institute on Alcohol Abuse and Alcoholism, NIH Research Priorities and Procedures The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is one of the 27 institutes and centers that comprise the National Institutes of Health (NIH). NIAAA supports and conducts research on the impact of alcohol use on human health and well-being. It is the largest funder of alcohol...
Adults with fetal alcohol spectrum disorders (FASD) may have an increased risk of type 2 diabetes, and other metabolic abnormalities such as low HDL cholesterol and elevated levels of triglycerides compared to people without FASD, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. The research...